Public Company News
HanchorBio Presents First-in-Human Data of HCB101 Monotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma at ASH 2025
Early Phase 1 monotherapy data demonstrate cytopenia-sparing safety, broad pharmacologic window, and early clinical activity in relapsed/refractory non-Hodgkin lymphoma (NHL) TAIPEI, SHANGHAI, and SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage b...
2025-12-08 20:00
1121
51Talk Online Education Group Announces New Share Repurchase Program
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, today announced that its board of directors has authorized a new share repurchase program under whi...
2025-12-08 19:35
2096
Huya Announces January 7, 2026 Open Beta Launch for Goose Goose Duck Mobile in Chinese Mainland
GUANGZHOU, China, Dec. 8, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today announced that the popular social deduction gameGoose Goose Duck mobile, co‑published by Huya and Kingsoft Shiyou in the Chinese mainl...
2025-12-08 19:30
1012
51Talk Online Education Group Announces Third Quarter 2025 Results
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the third quarter endedSeptember 30, 2025. Third Quarter 2025 F...
2025-12-08 19:30
3475
MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- MetaOptics Ltd. (Catalist: 9MT) ("MetaOptics" or the "Company"),a leading-edge semiconductor optics company pioneering metalens technology, will unveil five new proprietary metalens-powered consumer electronics at CES 2026 fromJanuary 6-9, 2026, in Las Veg...
2025-12-08 18:30
1265
Allison Worldwide Expands Global Leadership with New Europe CEO
Former Hotwire UK CEO and Edelman MD Jeremy Lucas to turbocharge Allison's European capabilities LONDON, Dec. 8, 2025 /PRNewswire/ -- Allison Worldwide, part of Stagwell (STGW), has announced the appointment ofJeremy Lucas as CEO, Europe. Based in London, Lucas will integrate and grow the agency...
2025-12-08 18:00
1747
Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight
- ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss. - ASC30 titrated weekly to target dose demonstrated approximately one-half the rate of vomiting observed w...
2025-12-08 17:40
1272
DAR GLOBAL AND ART DISTRICT REAL ESTATE DEVELOPMENT ANNOUNCE 'MAD', MUSCAT'S MARINE, ART & DIGITAL DISTRICT
MUSCAT, Oman, Dec. 8, 2025 /PRNewswire/ -- Dar Global (LSE: DAR), the London -listed luxury real estate developer, in partnership with Art District Real Estate Development, today announced the start of the collaboration to launch and develop 'MAD', Muscat Marine, Art & Digital District, a transfor...
2025-12-08 17:14
1493
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
- First anthrax vaccine developed using recombinant DNA technology - Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global biopharmaceutical company, today announced the first sh...
2025-12-08 14:36
1034
Riyadh Air and IBM Partner to Launch World's First AI-Native Airline
Riyadh Air's AI‑powered operations create agility across the business and unify
employee and guest experiences, setting a new benchmark in aviation
RIYADH, Saudi Arabia and ARMONK, N.Y., Dec. 8, 2025 /PRNewswire/ -- At IBM
ThinkRiyadh 2025, IBM (NYSE: IBM
2025-12-08 13:01
1033
NOVOSENSE Successfully Listed on HKEX, Strengthening Its Foundation to Serve Global Customers
HONG KONG, Dec. 8, 2025 /PRNewswire/ -- On 8 December 2025, NOVOSENSE Microelectronics (Stock Codes: 02676.HK; 688052.SH) was officially listed on the Main Board of the Hong Kong Stock Exchange, successfully establishing a dual-capital platform across the A-share and H-share markets. This milesto...
2025-12-08 12:10
1117
XCMG Flagship Mining Trucks Depart for World-Class Simandou Project, Delivering Key Chinese Technology to Global Mining Development
XUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- XCMG Machinery (SHE:000425) has commenced the shipment of its flagship mining trucks from its intelligent manufacturing base inChina. The equipment is destined for the SimFer mine, part of the Simandou iron ore project inGuinea, West Africa, marking a s...
2025-12-08 10:49
1299
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 10:08
1516
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 7, 2025 /PRNewswire/ -- From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) delivered an oral presentation o...
2025-12-08 10:00
982
Cebu Pacific Rolls Out an Early Christmas Surprise with 12.12 Seat Sale
Fares as Low as HKD 1 MANILA, Philippines, Dec. 8, 2025 /PRNewswire/ -- Cebu Pacific (PSE: CEB), the Philippines' leading carrier, spreads holiday cheer early as it unwraps its 12.12 Super Seat Fest, giving travelers the chance to treat themselves to a well-deserved vacation that they can look f...
2025-12-08 10:00
983
Cebu Pacific Rolls Out an Early Christmas Surprise with 12.12 Seat Sale
Fares as Low as TWD 1 MANILA, Philippines, Dec. 8, 2025 /PRNewswire/ -- Cebu Pacific (PSE: CEB), the Philippines' leading carrier, spreads holiday cheer early as it unwraps its 12.12 Super Seat Fest, giving travelers the chance to treat themselves to a well-deserved vacation that they can look f...
2025-12-08 10:00
761
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2025-12-08 09:02
1198
Daesang Group's "Vietnam Scholarship Quiz Show" Advances Youth Talent Development Through Respect
* Record participation as over 100,000 students nationwide compete in Vietnam's premier academic quiz show * Hanoi student Đinh Bảo Khánh earns top honor, receives a 200 million VND scholarship SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Daesang Group announced that the "Vietnam Scholar...
2025-12-08 09:00
997
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 08:15
1006
ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed
MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in Part 2 (randomized treatment expansion) of its ProstACT Global Phase 3 study evaluating its lead prostate can...
2025-12-08 06:08
901
Week's Top Stories
Most Reposted
Colebrook Bosson Saunders Launches Lana: An Adaptable Laptop Stand Engineered for Hybrid Work
[Picked up by 305 media titles]
2026-01-12 16:16
Ready Server Announces Strategic Expansion into Japan with AT TOKYO Data Centre
[Picked up by 300 media titles]
2026-01-13 13:16
CAYIN AI: Revolutionizing Creativity and Global Communication
[Picked up by 300 media titles]
2026-01-12 16:34
Novo Nordisk International Operations Commits to Veeva Vault CRM
[Picked up by 290 media titles]
2026-01-08 09:05Courtyard by Marriott Phuket, Patong Beach Resort: The Ultimate Family-Friendly Destination in 2026
[Picked up by 284 media titles]
2026-01-08 12:01
Most Read
J&T Express Hits Record 30 Billion Parcel Volume in 2025 with 22.2% YoY Growth
2026-01-07 06:53
6625
